Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

Rai C, Ruan H, Li X, Li W, Jeong HH, Song C, Liu P, Chang Y, Fang H, Kumar S U, Sun Y, You MJ, Guan D, Liu Z, Han L, Hou X, Sun Z

Open source

DOI
10.1038/s41392-026-02698-1
Published
2026 Jun 5
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02698-1,
  title = {Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.},
  author = {Rai C and Ruan H and Li X and Li W and Jeong HH and Song C and Liu P and Chang Y and Fang H and Kumar S U and Sun Y and You MJ and Guan D and Liu Z and Han L and Hou X and Sun Z},
  year = {2026},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-026-02698-1},
  url = {https://doi.org/10.1038/s41392-026-02698-1}
}

RIS

TY  - JOUR
TI  - Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.
AU  - Rai C
AU  - Ruan H
AU  - Li X
AU  - Li W
AU  - Jeong HH
AU  - Song C
AU  - Liu P
AU  - Chang Y
AU  - Fang H
AU  - Kumar S U
AU  - Sun Y
AU  - You MJ
AU  - Guan D
AU  - Liu Z
AU  - Han L
AU  - Hou X
AU  - Sun Z
PY  - 2026
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-026-02698-1
UR  - https://doi.org/10.1038/s41392-026-02698-1
ER  - 

APA

C, R., H, R., X, L., W, L., HH, J., C, S., P, L., Y, C., H, F., U, K. S., Y, S., MJ, Y., D, G., Z, L., L, H., X, H., & Z, S. (2026). Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02698-1

Source records